Corpus Intelligence DCF — KINGS DAUGHTERS MEDICAL CENTER 2026-04-26 02:07 UTC
DCF — KINGS DAUGHTERS MEDICAL CENTER
Enterprise Value: $-124.4M
🛡️ Public data only — no PHI permitted on this instance.
$-124.4M
Enterprise Value
$-39.9M
PV of Cash Flows
$-84.5M
PV of Terminal Value
$-136.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth

Cash Flow Projections

PROJ
YearRevenueEBITDAMarginFCFPV(FCF)
Year 1$94.3M$-7.4M-8.0%$-11.4M$-10.4M
Year 2$97.1M$-6.7M-7.0%$-10.8M$-8.9M
Year 3$100.0M$-5.9M-6.0%$-10.1M$-7.6M
Year 4$103.0M$-5.6M-5.0%$-9.9M$-6.8M
Year 5$106.1M$-5.5M-5.0%$-10.0M$-6.2M

Interpretation

INT

At a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-124.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.

Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.

Assumptions

ASSM
revenue base$91.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08396671471772052
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5